ES8105736A1 - Un procedimiento para la preparacion de compuestos de tia- diazolo- y oxadiazolo-tetrahidroisoquinolina - Google Patents

Un procedimiento para la preparacion de compuestos de tia- diazolo- y oxadiazolo-tetrahidroisoquinolina

Info

Publication number
ES8105736A1
ES8105736A1 ES492971A ES492971A ES8105736A1 ES 8105736 A1 ES8105736 A1 ES 8105736A1 ES 492971 A ES492971 A ES 492971A ES 492971 A ES492971 A ES 492971A ES 8105736 A1 ES8105736 A1 ES 8105736A1
Authority
ES
Spain
Prior art keywords
preparing
compositions containing
tetrahydroisoquinoline derivatives
tetrahydroisoquinoline
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES492971A
Other languages
English (en)
Other versions
ES492971A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline LLC
Original Assignee
SmithKline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Corp filed Critical SmithKline Corp
Publication of ES8105736A1 publication Critical patent/ES8105736A1/es
Publication of ES492971A0 publication Critical patent/ES492971A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

UN PROCEDIMIENTO PARA LA PREPARACION DE COMPUESTOS DE TIADIAZOLO Y OXADIAZOLOTETRAHIDROISOQUINOLINA DE FORMULA (I), DONDE X ES AZUFRE U OXIGENO Y SUS ISOMEROS. EL PROCESO CONSISTE, CUANDO X ES AZUFRE, EN CICLIZAR -2-ACETIL-8(7)-AMINO-7(8)-R-TIO-1,2,3,4-TETRAHIDROISOQUINOLINA POR DIAZOTACION E HIDROLISIS. CUANDO X ES OXIGENO CONSISTE EN CICLIZAR 2-ACETIL-8(7)-AMINO-7(8)-OXI-1,2,3,4-TETRAHIDROISOQUINOLINA, DIAZOTAR Y NEUTRALIZAR. ESTOS COMPUESTOS ACTUAN COMO INHIBIDORES FARMACEUTICOS DE LA ENCIMA N-METIL-TRANSFERASA DE FENILETANOLAMINA. *FORMULA*
ES492971A 1979-07-02 1980-07-01 Un procedimiento para la preparacion de compuestos de tia- diazolo- y oxadiazolo-tetrahidroisoquinolina Granted ES492971A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5434379A 1979-07-02 1979-07-02

Publications (2)

Publication Number Publication Date
ES8105736A1 true ES8105736A1 (es) 1981-06-01
ES492971A0 ES492971A0 (es) 1981-06-01

Family

ID=21990408

Family Applications (1)

Application Number Title Priority Date Filing Date
ES492971A Granted ES492971A0 (es) 1979-07-02 1980-07-01 Un procedimiento para la preparacion de compuestos de tia- diazolo- y oxadiazolo-tetrahidroisoquinolina

Country Status (30)

Country Link
EP (1) EP0023761B1 (es)
JP (1) JPS5610192A (es)
KR (1) KR840000396B1 (es)
AR (1) AR225925A1 (es)
AT (1) ATE6515T1 (es)
AU (1) AU531641B2 (es)
BG (1) BG51250A3 (es)
CA (1) CA1129415A (es)
CS (1) CS215064B2 (es)
DD (1) DD151750A5 (es)
DE (1) DE3066826D1 (es)
DK (1) DK151029C (es)
ES (1) ES492971A0 (es)
FI (1) FI67221C (es)
GR (1) GR69206B (es)
HU (1) HU179382B (es)
IE (1) IE50290B1 (es)
IL (1) IL60426A (es)
IN (1) IN160542B (es)
MX (1) MX6317E (es)
NO (1) NO801951L (es)
NZ (1) NZ194156A (es)
PH (1) PH17042A (es)
PL (2) PL127098B1 (es)
PT (1) PT71458A (es)
RO (1) RO79707A (es)
SU (1) SU1072809A3 (es)
YU (1) YU171180A (es)
ZA (1) ZA802987B (es)
ZW (1) ZW14680A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352809A (en) * 1981-09-04 1982-10-05 Smithkline Corporation Method of producing alpha2 antagonism

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3988339A (en) * 1974-02-08 1976-10-26 Smithkline Corporation Pharmaceutical compositions and methods of inhibiting phenylethanolamine N-methyltransferase
US3939164A (en) * 1974-02-08 1976-02-17 Smithkline Corporation 7 AND 8-Halo substituted 1,2,3,4-tetrahydroisoquinoline compounds

Also Published As

Publication number Publication date
IL60426A0 (en) 1980-09-16
AR225925A1 (es) 1982-05-14
CS215064B2 (en) 1982-07-30
IE801352L (en) 1981-01-02
MX6317E (es) 1985-04-01
HU179382B (en) 1982-10-28
IE50290B1 (en) 1986-03-19
SU1072809A3 (ru) 1984-02-07
ATE6515T1 (de) 1984-03-15
IN160542B (es) 1987-07-18
FI802112A (fi) 1981-01-03
DE3066826D1 (en) 1984-04-12
PL127098B1 (en) 1983-09-30
DK274280A (da) 1981-01-03
CA1129415A (en) 1982-08-10
BG51250A3 (en) 1993-03-15
FI67221C (fi) 1985-02-11
ZA802987B (en) 1981-05-27
DD151750A5 (de) 1981-11-04
KR830002791A (ko) 1983-05-30
YU171180A (en) 1983-09-30
NZ194156A (en) 1983-03-15
PL230619A1 (es) 1981-12-11
AU531641B2 (en) 1983-09-01
PL225377A1 (es) 1981-08-21
ES492971A0 (es) 1981-06-01
EP0023761B1 (en) 1984-03-07
DK151029C (da) 1988-03-07
KR840000396B1 (ko) 1984-03-30
EP0023761A1 (en) 1981-02-11
PH17042A (en) 1984-05-17
NO801951L (no) 1981-01-05
FI67221B (fi) 1984-10-31
GR69206B (es) 1982-05-07
IL60426A (en) 1984-03-30
RO79707A (ro) 1982-08-17
JPS5610192A (en) 1981-02-02
DK151029B (da) 1987-10-12
PT71458A (en) 1980-07-01
AU5967780A (en) 1981-01-15
ZW14680A1 (en) 1980-09-24

Similar Documents

Publication Publication Date Title
DE3166441D1 (en) Novel antihistamines, process for their preparation and pharmaceutical compositions containing them
MX9705273A (es) Inhibidores de prenil transferasas.
ATE22562T1 (de) 6-substituierte s-triazolo(3,4-a)phthalazinderivate.
PT70707A (en) Process for preparing n-benzyl-imidazoles as selective inhibitors of the thromboxane synthetase enzyme and pharmaceutical compositions
HUP0000323A2 (hu) N-Szubsztituált 2-ciano-pirrolidin-származékok, eljárás előállításukra, valamint a vegyületeket tartalmazó gyógyszerkészítmények
UA74325C2 (uk) ГЕТЕРОЦИКЛІЧНІ ІНГІБІТОРИ р38, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЇХ МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ ЗА ЇХ ДОПОМОГОЮ
EP1049459A4 (en) ORAL LIQUID COMPOSITIONS
ZA973647B (en) Inhibitors of metalloprotease, process for preparing them and pharmaceutical compositions containing them.
YU211087A (en) Process for obtaining new n-substituted benzimidazolic derivatives
ES8307744A1 (es) Un metodo para la preparacion de nuevos derivados de sales de metales alcalinos de acidos 2-pirrolidon-4-carboxilicos.
MY106202A (en) Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof.
DE3167879D1 (en) Indole thromboxane synthetase inhibitors, processes for their preparation, and pharmaceutical compositions containing them
EP1026157A3 (en) Method for the synthesis of huperzine A and analogs thereof and compounds useful therein
ES475633A1 (es) Procedimiento para la obtencion de derivados de 1-n-4,6-di-0-(aminoglicosil)-1,3-diamino-ciclitol.
DE3275545D1 (en) Indole thromboxane synthetase inhibitors, processes for their preparation, and pharmaceutical compositions containing them
BG41125A3 (en) Method for preparing benzamides
ES8103043A1 (es) Procedimiento para la obtencion de derivados de 2-hidroxime-til-3,4,5-trihidroxipiperidinas
ZA824789B (en) Indole thomboxane synthetase inhibitors, processes for their preparation, and pharmaceutical compositions containing them
ES8105736A1 (es) Un procedimiento para la preparacion de compuestos de tia- diazolo- y oxadiazolo-tetrahidroisoquinolina
ES8305783A1 (es) Procedimiento para la obtencion de derivados de aminociclitol saturados.
AU7156681A (en) Oligopeptides with specific inhibiting properties of collageninduced aggregation, process for preparing the same and pharmaceutical compositions containing them
OA08165A (fr) Nouveaux dérivés thiosulfonates, leur procédé de préparation ainsi que les compositions pharmaceutiques les contenant.
IL61580A (en) Quinoline derivatives,the preparation of 1-(8-quinolyl)-2-pyrrolidinone and pharmaceutical compositions containing it
ES8203334A1 (es) Procedimiento para la obtencion de dehidropeptidos
ES473316A1 (es) Procedimiento para la obtencion de 1,4-dihidropiridazinas.